Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001283761 | SCV001521345 | pathogenic | Congenital glucose-galactose malabsorption | 2020-02-16 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease-causing [PMID: 12139397, 28753187] |
Gene |
RCV002225822 | SCV002504256 | pathogenic | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In addition, in silico splice predictors suggest this variant may lead to abnormal gene splicing; This variant is associated with the following publications: (PMID: 12139397, 28753187) |
Center for Genomic Medicine, |
RCV001283761 | SCV004805139 | pathogenic | Congenital glucose-galactose malabsorption | 2024-03-17 | criteria provided, single submitter | research | |
Biochemical Molecular Genetic Laboratory, |
RCV001283761 | SCV001469130 | pathogenic | Congenital glucose-galactose malabsorption | 2020-08-07 | no assertion criteria provided | clinical testing |